Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Jackisch

Showing results (21-30 of 231) with videos related to

Pageof 24
Sort By:
Breast Care (Basel, Switzerland)|June 1, 2012
News from the San Antonio Breast Cancer Symposium 2009Michael Untch, Ingo Bauerfeind, Christian Jackisch, et al.
Advances in Therapy|January 6, 2022
White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an ExampleChristian Jackisch, Federico Manevy, Suzanne Frank, et al.
Pathologie (Heidelberg, Germany)|December 6, 2022
New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosisCarsten Denkert, Annette Lebeau, Hans Ulrich Schildhaus, et al.
Breast Care (Basel, Switzerland)|June 20, 2014
Optimal Sequencing of Anti-HER2 TherapyHans-Joachim Lück, Michael Untch, Christian Jackisch, et al.
Pathologie (Heidelberg, Germany)|October 13, 2022
[New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis]Carsten Denkert, Annette Lebeau, Hans Ulrich Schildhaus, et al.
The Lancet. Oncology|November 9, 2002
Endobronchial mucosal metastases in breast cancer: a rare metastatic patternChristian Jackisch, B Gast, Agnes Bánkfalvi, et al.
Breast Care (Basel, Switzerland)|August 3, 2018
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2018Cornelia Liedtke, Christian Jackisch, Marc Thill, et al.
Seminars in Oncology|October 19, 2004
Future options with trastuzumab for primary systemic and adjuvant therapyJosé Baselga, Luca Gianni, Charles Geyer, et al.
Cancer Management and Research|December 7, 2018
Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?Sherko Kümmel, Christian Jackisch, Volkmar Müller, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 2002
Clinical management of breast cancer in males: a report of four casesJoerg Heinig, Christian Jackisch, Achim Rody, et al.
Pageof 24

Showing results (21-30 of 231) with videos related to

Sort By:
Pageof 24
Breast Care (Basel, Switzerland)|June 1, 2012
News from the San Antonio Breast Cancer Symposium 2009Michael Untch, Ingo Bauerfeind, Christian Jackisch, et al.
Advances in Therapy|January 6, 2022
White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an ExampleChristian Jackisch, Federico Manevy, Suzanne Frank, et al.
Pathologie (Heidelberg, Germany)|December 6, 2022
New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosisCarsten Denkert, Annette Lebeau, Hans Ulrich Schildhaus, et al.
Breast Care (Basel, Switzerland)|June 20, 2014
Optimal Sequencing of Anti-HER2 TherapyHans-Joachim Lück, Michael Untch, Christian Jackisch, et al.
Pathologie (Heidelberg, Germany)|October 13, 2022
[New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis]Carsten Denkert, Annette Lebeau, Hans Ulrich Schildhaus, et al.
The Lancet. Oncology|November 9, 2002
Endobronchial mucosal metastases in breast cancer: a rare metastatic patternChristian Jackisch, B Gast, Agnes Bánkfalvi, et al.
Breast Care (Basel, Switzerland)|August 3, 2018
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2018Cornelia Liedtke, Christian Jackisch, Marc Thill, et al.
Seminars in Oncology|October 19, 2004
Future options with trastuzumab for primary systemic and adjuvant therapyJosé Baselga, Luca Gianni, Charles Geyer, et al.
Cancer Management and Research|December 7, 2018
Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?Sherko Kümmel, Christian Jackisch, Volkmar Müller, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 2002
Clinical management of breast cancer in males: a report of four casesJoerg Heinig, Christian Jackisch, Achim Rody, et al.
Pageof 24